Lansoprazole Delayed Release Capsules used to treat peptic ulcer disease, gastroesophagealreflux disease, and Zollinger Ellisonsyndrome. Effectiveness is similar to other proton pump inhibitors (PPIs).

Tags: Lansoprazole Delayed Release Tablets manufacturer,Lansoprazole Delayed Release Tablets exporter,Lansoprazole Delayed Release Tablets supplier,Lansoprazole Delayed Release Tablets, Lansoprazole Delayed Release ,whogmp approved, Lansoprazole Delayed Release tablets manufacturer and supplier, Lansoprazole Delayed Release,Tablets distributor, Lansoprazole Delayed Release  Tablets   drop shipper,Lansoprazole Delayed Release  Tablets 30mg, Lansoprazole Delayed Release  Tablets 30 mg supplier, Lansoprazole Delayed Release Tablets 30 mg .

ISO/GMP/c-GMP/WHOGMP/ NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturing facility in Gujarat, India.

Registration: Saintroy Lifescience is interested in registration of own brand or customer brands in ministry of health of client's country and we also provide the products samples, COA, COPP, ACTD or CTD Dossier, DMF, Manufacturing license, Free sale certificate and other required documents.

Export Country : Saintroy Lifescience  Lansoprazole Delayed Release  Tablets   export to USA, Canada, Germany, Europe, France, Ghana,Nigeria, Kenya, Senegal, Sudan, UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru,Chile, Somalia, Philippines, Myanmar, Maldives, Thailand, Singapore, Malaysia,Hong Kong, China, Zimbabwe, Togo, Burkina Faso, Niger, Guinea Bissau, Congo,Democratic of republic, Ivory Costa, Oman, Guatemala, Nicaragua, Salvador,Qatar, Costa Rica, Panama, Cuba, Colombia, Bolivia, Argentine, Algeria, Guyana,Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.